Mark Mulvihill
4PUBLICATIONS
36CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Sep 04, 2025
In Vivo Tumor Growth Control by General Control Nonderepressible 2-Targeting Agents Results from Kinase Activation.Feven Tameire, Paulina Wojnarowicz, Crissy Dudgeon
|Aug 20, 2025
In Vivo Tumor Growth Control by General Control Nonderepressible 2-Targeting Agents Results from Kinase Activation.Feven Tameire, Paulina Wojnarowicz, Crissy Dudgeon
|Nov 20, 2023
A PERK-Specific Inhibitor Blocks Metastatic Progression by Limiting Integrated Stress Response-Dependent Survival of Quiescent Cancer Cells.Veronica Calvo, Wei Zheng, Anna Adam-Artigues
|Sep 21, 2023
PERK Inhibition by HC-5404 Sensitizes Renal Cell Carcinoma Tumor Models to Antiangiogenic Tyrosine Kinase Inhibitors.Michael E Stokes, Veronica Calvo, Sho Fujisawa
Pageof 1
Frequent Collaborators
4 joint publications
Sho Fujisawa
4 joint publications
David Surguladze
3 joint publications
Crissy Dudgeon
3 joint publications
Eric S Lightcap
3 joint publications
Nandita Bose
3 joint publications
Alan C Rigby
3 joint publications
Simon J Taylor
2 joint publications
Michael E Stokes
2 joint publications
Veronica Calvo
2 joint publications
Kirk A Staschke
